By Patrick Wingrove (Reuters) -Three people sought medical treatment for dangerously low blood sugar in the U.S. last year after taking suspected fake versions of Novo Nordisk’s diabetes drug Ozempic, America’s Poison Centers told Reuters. One person also experienced hypoglycemia in 2023 after injecting a compounded version of Ozempic, said the organization, which represents 55 regional poison centers across the country and works with the U.S. Food and Drug Administration to identify public health risks. Ozempic and similar diabetes medicines have been increasingly used off label for weight lo…